NCCN Clinical Practice Guidelines in Oncology™: Cancer-Related Fatigue

The National Comprehensive Cancer Network (NCCN) has developed guidelines to evaluate and treat cancer patients who are experiencing heightened fatigue that interferes with activities of daily living.

Access the guidelines here

Updated Results for SUTENT in mRCC

Now available: Journal of Clinical Oncology reprint on overall survival (OS) with sunitinib versus interferon alfa (IFNα) as first-line treatment of metastatic renal cell carcinoma (mRCC). Access the reprint now.

Leading experts discuss key issues in mRCC

Now available: Clinical Perspectives in the Treatment of mRCC. In this video, two leading experts examine several topics concerning mRCC, including:

• The evolving treatment landscape
• Clinical factors shaping treatment decisions
• Managing patients in first-line therapy
• The NCCN recommended guidelines in mRCC

Watch this videocast now

SUTENT Patient Call Center Now Open

Patients can call 1-877-5-SUTENT Monday through Friday from 8 AM To 7 PM CT to speak to trained oncology nurses. The nurses do not provide medical advice, but reinforce general information about SUTENT, including:

• Potential side effects
• Treatment information
• RCC information

View the patient call center brochure.
View the Spanish patient call center brochure.